Rohini Chavare: PGT Technology Enhancements Driving IVF Success Rates
Rohini Chavare, Assistant Manager at Marketsand Markets, shared a post on LinkedIn:
“Preimplantation Genetic Testing (PGT): Advancing Precision in IVF Embryo Selection
Download PDF Brochure.
Preimplantation Genetic Testing (PGT) is transforming assisted reproduction by enabling early detection of genetic abnormalities before embryo implantation. By combining advanced technologies like NGS, PCR, SNP analysis, and Array CGH, PGT helps improve IVF success rates and supports informed reproductive decisions.
As genetic screening technologies continue to evolve, PGT is playing a critical role in reducing inherited disease risk and improving patient outcomes in reproductive medicine.
The preimplantation genetic testing market is projected to reach USD 1,135.0 million by 2030 from USD 690.2 million in 2025, at a CAGR of 10.5% from 2025 to 2030.
The procedure type segment comprises preimplantation genetic screening and preimplantation genetic diagnosis. Preimplantation genetic screening is highly demanded with the rising demand for assisted reproductive technologies.
Key technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH). NGS dominates the market with increasing use of these systems in fertility clinics and research institutes for preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD).
Major market players have adopted organic and inorganic strategies, including product launches, partnerships, and investments. For instance, in July 2023, Thermo Fisher Scientific Inc. (US) launched two new NGS-based test kits to support preimplantation genetic testing for aneuploidy (PGT-A), commonly used in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 17, 2026, 13:28Dinesh Velu Rajan: Exploring the Role of Dysbiosis in ART Outcomes
-
Feb 17, 2026, 13:19Dinesh Velu Rajan: Revolutionizing Male Infertility Diagnosis with Epigenetic Tools
-
Feb 17, 2026, 13:17Insights into Antiphospholipid Syndrome from Experts – American College of Rheumatology
-
Feb 17, 2026, 13:15Jecko Thachil: Unraveling Russell’s Viper Venom in Antiphospholipid Syndrome
-
Feb 17, 2026, 13:10Gharam Mohammad: Uterine Factors for Personalized IVF Strategies
-
Feb 17, 2026, 13:07Ashok Yadav: Chronic Chorioamnionitis with Eosinophils
-
Feb 17, 2026, 12:48Plastic Pollution in Human Reproduction: Should We Worry? – RBMO
-
Feb 17, 2026, 12:39Applications Open for ESHRE Nurses and Midwives Certification 2026 – ESHRE
-
Feb 17, 2026, 12:28Neonatal Outcomes After IVF and IUI Compared With Unassisted Sibling Births – Fertility and Sterility